Clinical Trial Update: Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating somatostatin receptor imaging in relapsing and refractory multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Jules Bordet Institute | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED